These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19597685)
1. Artificial oxygen carriers as a possible alternative to red cells in clinical practice. Barbosa FT; Jucá MJ; Castro AA; Duarte JL; Barbosa LT Sao Paulo Med J; 2009 May; 127(2):97-100. PubMed ID: 19597685 [TBL] [Abstract][Full Text] [Related]
2. Alternatives to allogeneic blood transfusions. Pape A; Habler O Best Pract Res Clin Anaesthesiol; 2007 Jun; 21(2):221-39. PubMed ID: 17650774 [TBL] [Abstract][Full Text] [Related]
5. [Artificial oxygen carriers. Alternatives to homologous blood transfusion?]. Habler O; Kleen M; Messmer K Zentralbl Chir; 1999; 124(4):260-70. PubMed ID: 10355079 [TBL] [Abstract][Full Text] [Related]
6. Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences. Haldar R; Gupta D; Chitranshi S; Singh MK; Sachan S Cardiovasc Hematol Agents Med Chem; 2019; 17(1):11-16. PubMed ID: 31204626 [TBL] [Abstract][Full Text] [Related]
7. [Artificial oxygen carriers as an alternative to red blood cell transfusion]. Habler O; Pape A; Meier J; Zwissler B Anaesthesist; 2005 Aug; 54(8):741-54. PubMed ID: 16021390 [TBL] [Abstract][Full Text] [Related]
9. [Current aspects in red blood cell substitutes]. Wang Y; Pan J; Yu Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164 [TBL] [Abstract][Full Text] [Related]
11. The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation. Spahn DR; Kocian R Can J Anaesth; 2003; 50(6 Suppl):S41-7. PubMed ID: 14629052 [No Abstract] [Full Text] [Related]
12. Future perspectives in blood transfusion. Waschke KF; Quintel M; Kerger H; Lenz C Acta Anaesthesiol Scand Suppl; 1996; 109():143-7. PubMed ID: 8901987 [No Abstract] [Full Text] [Related]
13. Delaying blood transfusion in experimental acute anemia with a perfluorocarbon emulsion. Cabrales P; Carlos Briceño J Anesthesiology; 2011 Apr; 114(4):901-11. PubMed ID: 21326091 [TBL] [Abstract][Full Text] [Related]
14. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Kim HW; Greenburg AG Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945 [TBL] [Abstract][Full Text] [Related]
15. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. LaMuraglia GM; O'Hara PJ; Baker WH; Naslund TC; Norris EJ; Li J; Vandermeersch E J Vasc Surg; 2000 Feb; 31(2):299-308. PubMed ID: 10664499 [TBL] [Abstract][Full Text] [Related]
16. Artificial oxygen carriers for trauma: myth or reality. Mackenzie CF; Bucci C Hosp Med; 2004 Oct; 65(10):582-8. PubMed ID: 15524336 [TBL] [Abstract][Full Text] [Related]
17. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives. Spence RK Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058 [TBL] [Abstract][Full Text] [Related]
20. Use of a human polymerized hemoglobin solution as an adjunct to acute normovolemic hemodilution during complex abdominal aortic reconstruction. Norris EJ; Ness PM; Williams GM J Clin Anesth; 2003 May; 15(3):220-3. PubMed ID: 12770661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]